This event has finished
Dear member,
On behalf of Prof. Michel Delforge, chair of the MM committee, we are cordially inviting you to the upcoming:
Symposium “Optimizing the use of novel agents in multiple myeloma: recommendations on how to prevent and manage adverse event"
Date: Friday 20 October 2017
Location: Hof ter Musschen
Place: Brussels
Programme
Chairs: Chantal Doyen en Michel Delforge
15:00 - 15:10 Welcome
15:10 - 15:50 Part 1: Immunomodulatory drugs
15:10 2 case reports: Dr. Isabelle Vandebroek (AZ Nikolaas), Prof. Marie-Christiane Vekemans (UCL, Saint-Luc)
15:20 resentation: Prof. Nathalie Meuleman (Institut Jules Bordet)
15:50 - 16:30 Part 2: Proteasome inhibitors
15:50 2 case reports: Dr. Karel Fostier (UZ Brussel), Prof. Jo Caers (CHU de Liège)
16:00 Presentation: Prof. Michel Delforge (UZ Leuven)
16:30 - 17:00 Coffee break
17:00 - 17:40 Part 3: Monoclonal antibodies
17:00 1 case report: Dr. Philip Vlummens (UZ Gent)
17:05 Presentation: Dr. Niels Van de Donk (Vrije Universiteit Amsterdam, the Netherlands)
17:40 - 18:10 Part 4: Conventional drugs (steroids, chemo) and future agents
Presentation: Prof. Chantal Doyen (UCL, Mont-Godinne)
18:10 - 18-15 Concluding remarks: Prof. Michel Delforge
18:15 - 18:45 Drinks
